LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Elevated Cholesterol Reported in Blood Tests on Children

By LabMedica International staff writers
Posted on 28 Jul 2010
The concentration of low-density lipoprotein (LDL) in the blood is a guide to the health of the individual. Increased LDL cholesterol is indicative of type 2 diabetes and early heart attacks.

The normal value of LDL for children ages 2-19 years is under 130 mg/dL. Serum concentrations of total cholesterol and triglycerides are determined using enzymatic procedures. Children are seldom checked for their cholesterol levels as screening them has until recently not been considered a priority.

In a study, 20,266 fifth-grade children, had blood taken and a lipid panel analysis was performed. The panel included total cholesterol, triglycerides, and LDL and, very-low density lipoprotein (VLDL) serum levels (Abbott, North Chicago, IL, USA). The LDL and VLDL concentration were measured after heparin–calcium precipitation and determined by densitometric (electrophoretic) ratio and cholesterol content of the two lipoproteins.

The study found that among the 11-year-olds who met current cholesterol screening guidelines, 8.3% had LDL cholesterol levels of 130 mg/dL or higher, and 1.2% had LDL cholesterol levels of 160 mg/dL or higher. Among the 11-year-olds who would not have been screened under current guidelines, 9.5% had LDL cholesterol levels of 130 mg/dL or higher and 1.7% had LDL cholesterol levels of 160 mg/dL or higher.

More than 70% of the 20,266 children who were screened would have qualified for routine cholesterol screening, according to current U.S. National Cholesterol Education Program (NCEP; Bethesda, MD, USA) guidelines. But even more surprising was how many children had high cholesterol even though they would not have qualified for routine screening. The study was performed at the West Virginia University, (West Virginia University, Morgantown, WV, USA).

William Neal, MD, professor of pediatrics at West Virginia University, said, "A lot of parents told us they did not even know children had cholesterol, let alone high cholesterol. Just as many children who would not have been screened ended up with severely high cholesterol levels as in the group that did qualify for screening based on family history.” One in three children with dangerously high cholesterol is missed by current screening recommendations. The study was published in July 2010 in Pediatrics.

Related Links:
Abbott
U.S. National Cholesterol Education Program
West Virginia University


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gel Cards
DG Gel Cards

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more